Department of Radiology
Found 18 results
Filters: Author is Vedvyas, Yogindra  [Clear All Filters]
2023
Yang Y, Louie R, Puc J, Vedvyas Y, Alcaina Y, Min IM, Britz M, Luciani F, Jin MM.  2023.  Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance.. Cancers (Basel). 15(23)
Yang Y, Yang H, Alcaina Y, Puc J, Birt A, Vedvyas Y, Gallagher M, Alla S, Riascos MCristina, McCloskey JE et al..  2023.  Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models.. Nat Commun. 14(1):2068.
2022
Alcaina Y, Yang Y, Vedvyas Y, McCloskey JE, Jin MM.  2022.  SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity.. Sci Rep. 12(1):20932.
2021
Yang Y, McCloskey JE, Yang H, Puc J, Alcaina Y, Vedvyas Y, Gallegos AAGomez, Ortiz-Sánchez E, de Stanchina E, Min IM et al..  2021.  Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.. Cancer Immunol Res. 9(10):1158-1174.
2020
Jung M, Yang Y, McCloskey JE, Zaman M, Vedvyas Y, Zhang X, Stefanova D, Gray KD, Min IM, Zarnegar R et al..  2020.  Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer.. Mol Ther Oncolytics. 18:587-601.
Gray KD, McCloskey JE, Vedvyas Y, Kalloo OR, Eshaky SEl, Yang Y, Shevlin E, Zaman M, Ullmann TM, Liang H et al..  2020.  PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer.. Clin Cancer Res. 26(22):6003-6016.
Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu Y-MS, Hsu J-M, van Basien K, Gaudet I et al..  2020.  Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.. Sci Rep. 10(1):12733.
Deh K, Zaman M, Vedvyas Y, Liu Z, Gillen KMcCabe, Malley PO', Bedretdinova D, Nguyen T, Lee R, Spincemaille P et al..  2020.  Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.. Sci Rep. 10(1):1171.
2019
Amor-Coarasa A, Kelly JM, Singh PK, Ponnala S, Nikolopoulou A, Williams C, Vedvyas Y, Jin MM, J Warren D, Babich JW.  2019.  [F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4.. Molecules. 24(8)
Guo H, Kommidi H, Vedvyas Y, McCloskey JE, Zhang W, Chen N, Nurili F, Wu AP, Sayman HB, Akin O et al..  2019.  A Fluorescent, [F]-Positron-Emitting Agent for Imaging Prostate-Specific Membrane Antigen Allows Genetic Reporting in Adoptively Transferred, Genetically Modified Cells.. ACS Chem Biol. 14(7):1449-1459.
Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu Y-MS, Hsu J-M, Van Besien K, Gaudet I et al..  2019.  Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.. Sci Rep. 9(1):10634.
2018
Kommidi H, Guo H, Nurili F, Vedvyas Y, Jin MM, McClure TD, Ehdaie B, Sayman HB, Akin O, Aras O et al..  2018.  F-Positron Emitting/Trimethine Cyanine-Fluorescent Contrast for Image-Guided Prostate Cancer Management.. J Med Chem. 61(9):4256-4262.
Amor-Coarasa A, Kelly J, Ponnala S, Vedvyas Y, Nikolopoulou A, Williams C, Jin MM, J Warren D, Babich JW.  2018.  [F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4.. Nucl Med Biol. 60:37-44.
2017
Min IM, Shevlin E, Vedvyas Y, Zaman M, Wyrwas B, Scognamiglio T, Moore MD, Wang W, Park S, Park S et al..  2017.  CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.. Clin Cancer Res. 23(24):7569-7583.
Park S, Shevlin E, Vedvyas Y, Zaman M, Park S, Hsu Y-MS, Min IM, Jin MM.  2017.  Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity.. Sci Rep. 7(1):14366.
2016
Vedvyas Y, Shevlin E, Zaman M, Min IM, Amor-Coarasa A, Park S, Park S, Kwon K-W, Smith T, Luo Y et al..  2016.  Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.. JCI Insight. 1(19):e90064.
2012
Gu X, Vedvyas Y, Chen X, Kaushik T, Hwang C-I, Hu X, Nikitin AY, Jin MM.  2012.  Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeast.. PLoS One. 7(1):e30680.
2010
Park S, Kang S, Veach AJ, Vedvyas Y, Zarnegar R, Kim J-Y, Jin MM.  2010.  Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions.. Biomaterials. 31(30):7766-75.